Global Sickle Cell Disease Treatment Market by Type (Hydroxyurea, Oxybryta, Adakveo, and others), By Application (Blood transfusion, Bone Marrow Transplants, and Pharmacotherapy and Others), By Route of Administration (Oral, Parenteral, and Others), By End-User, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2024-2032
- Published date: Oct 2023
- Report ID: 44935
- Number of Pages: 331
- Format:
-
keyboard_arrow_up
-
-
- Agios Pharmaceuticals
- Bristol-Myers Squibb
- CRISPR Therapeutics
- Editas Medicine
- Emmaus Life Sciences Inc.
- Medunic USA Inc.
- Novo Nordisk A/S Company Profile
- Vifor Pharma
- Other key Players
Our Clients
- 44935
- Oct 2023
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
